title: Careful selection of reference genes is required for reliable performance of RT-qPCR in human normal and cancer cell lines.
abstract: Reverse Transcription - quantitative Polymerase Chain Reaction (RT-qPCR) is a standard technique in most laboratories. The selection of reference genes is essential for data normalization and the selection of suitable reference genes remains critical. Our aim was to 1) review the literature since implementation of the MIQE guidelines in order to identify the degree of acceptance; 2) compare various algorithms in their expression stability; 3) identify a set of suitable and most reliable reference genes for a variety of human cancer cell lines. A PubMed database review was performed and publications since 2009 were selected. Twelve putative reference genes were profiled in normal and various cancer cell lines (n = 25) using 2-step RT-qPCR. Investigated reference genes were ranked according to their expression stability by five algorithms (geNorm, Normfinder, BestKeeper, comparative ΔCt, and RefFinder). Our review revealed 37 publications, with two thirds patient samples and one third cell lines. qPCR efficiency was given in 68.4% of all publications, but only 28.9% of all studies provided RNA/cDNA amount and standard curves. GeNorm and Normfinder algorithms were used in 60.5% in combination. In our selection of 25 cancer cell lines, we identified HSPCB, RRN18S, and RPS13 as the most stable expressed reference genes. In the subset of ovarian cancer cell lines, the reference genes were PPIA, RPS13 and SDHA, clearly demonstrating the necessity to select genes depending on the research focus. Moreover, a cohort of at least three suitable reference genes needs to be established in advance to the experiments, according to the guidelines. For establishing a set of reference genes for gene normalization we recommend the use of ideally three reference genes selected by at least three stability algorithms. The unfortunate lack of compliance to the MIQE guidelines reflects that these need to be further established in the research community.
authors.affiliation: Gynecological Research, Department of Biomedicine, University Hospital Basel, Basel, Switzerland. francis.jacob@unibas.ch
authors.forename: Francis
authors.initials: F
authors.lastname: Jacob
authors.forename: Rea
authors.initials: R
authors.lastname: Guertler
authors.forename: Stephanie
authors.initials: S
authors.lastname: Naim
authors.forename: Sheri
authors.initials: S
authors.lastname: Nixdorf
authors.forename: André
authors.initials: A
authors.lastname: Fedier
authors.forename: Neville F
authors.initials: NF
authors.lastname: Hacker
authors.forename: Viola
authors.initials: V
authors.lastname: Heinzelmann-Schwarz
mesh_terms: D000465:Algorithms; D045744:Cell Line, Tumor; D016206:Databases, Bibliographic; D015870:Gene Expression; D020043:Genes, Essential; D006801:Humans; D009363:Neoplasm Proteins / Q000235:genetics* / Q000378:metabolism; D009928:Organ Specificity; D017410:Practice Guidelines as Topic; D012015:Reference Standards; D015203:Reproducibility of Results; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000592:standards*
chemical_list: D009363:Neoplasm Proteins
references.citation: Clin Chem. 2004 Mar;50(3):509-15
references.pmid: 14726469
references.citation: Mol Cell Biol. 1988 Aug;8(8):3088-93
references.pmid: 2463471
references.citation: Mol Cell Probes. 2003 Oct;17(5):261-5
references.pmid: 14580401
references.citation: Proc Natl Acad Sci U S A. 1990 Jul;87(14):5273-7
references.pmid: 2164673
references.citation: Clin Chem. 2004 Sep;50(9):1678-80
references.pmid: 15331507
references.citation: Biotechnol Lett. 2004 Mar;26(6):509-15
references.pmid: 15127793
references.citation: Planta. 2012 Nov;236(5):1381-93
references.pmid: 22718310
references.citation: Anal Biochem. 2009 Nov 1;394(1):110-6
references.pmid: 19622337
references.citation: Cancer Res. 2004 Aug 1;64(15):5245-50
references.pmid: 15289330
references.citation: Clin Chem. 2009 Apr;55(4):611-22
references.pmid: 19246619
references.citation: Physiol Genomics. 2005 May 11;21(3):389-95
references.pmid: 15769908
references.citation: Genome Biol. 2002 Jun 18;3(7):RESEARCH0034
references.pmid: 12184808
references.citation: J Mol Endocrinol. 2005 Jun;34(3):597-601
references.pmid: 15956331
references.citation: Genome Res. 2002 Jun;12(6):996-1006
references.pmid: 12045153
references.citation: Mol Aspects Med. 2006 Apr-Jun;27(2-3):126-39
references.pmid: 16469371
references.citation: Science. 2002 Apr 19;296(5567):557-9
references.pmid: 11964485
references.citation: BMC Cancer. 2008 Nov 27;8:350
references.pmid: 19036168
references.citation: Biotechniques. 1999 Jan;26(1):112-22, 124-5
references.pmid: 9894600
references.citation: BMC Bioinformatics. 2008 Nov 01;9:465
references.pmid: 18976492
references.citation: Biochem Biophys Res Commun. 1990 Aug 31;171(1):431-8
references.pmid: 2118350
references.citation: Biochem Biophys Res Commun. 2004 Jan 23;313(4):856-62
references.pmid: 14706621
references.citation: Exp Hematol. 2002 Jun;30(6):503-12
references.pmid: 12063017
references.citation: Methods. 2010 Apr;50(4):215-6
references.pmid: 20215019
references.citation: BMC Mol Biol. 2006 Oct 06;7:33
references.pmid: 17026756
references.citation: BMC Dev Biol. 2005 Dec 03;5:27
references.pmid: 16324220
references.citation: J Biomol Tech. 2004 Sep;15(3):155-66
references.pmid: 15331581